This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Dna Repair-deficiency Disorders
Information about Dna Repair-deficiency Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Dna Repair-deficiency Disorders
Most recent studies have shown that Dna Repair-deficiency Disorders shares some biological mechanisms with anemia, ataxia, ataxia-telangiectasia, cockayne-syndrome, cytogenetic-abnormality, dna-repair-disorder, fanconi-anemia, genomic-instability, immunologic-deficiency-syndromes, malignant-neoplasms, microcephaly, microsatellite-instability, neoplasms, nervous-system-disorder, premature-aging-syndrome, primary-immune-deficiency-disorder, trichothiodystrophy-syndromes, turcot-syndrome-(disorder), xeroderma, xeroderma-pigmentosum.
Among the many pathways, these few ones have gauged particular interests from scientists studying Dna Repair-deficiency Disorders, and have been seen in publications frequently: Aging, Cell Adhesion, Cell Cycle, Cell Cycle Arrest, Cell Death, Chromatin Remodeling, Dna Repair, Dna Replication, Double-strand Break Repair, Heteroduplex Formation, Hypersensitivity, Meiosis, Mismatch Repair, Pigmentation, Regulation Of Gene Expression, Response To Gamma Radiation, Sister Chromatid Cohesion, System Development, Translesion Synthesis, V(d)j Recombination
Quite a number of genes have been found to play important roles in Dna Repair-deficiency Disorders, such as ATM, BLM, BRCA1, ERCC1, ERCC2, ERCC3, GTF2H5, LIG4, MLH1, MRC1, MSH2, MSH6, NBN, NHEJ1, PARP1, PMS2, PRKDC, TP53, WRN. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.